UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib

Annals of oncology, 2007-04, Vol.18 (4), p.752-760

2007

Volltextzugriff (PDF)

Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy

Annals of oncology, 2007-03, Vol.18 (3), p.447-452

2007

Volltextzugriff (PDF)

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer

Annals of oncology, 2018-08, Vol.29 (8), p.1701-1709

2018

Volltextzugriff (PDF)

New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions

Clinical cancer research, 1998-05, Vol.4 (5), p.1087-1100

1998

Volltextzugriff (PDF)

The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer

Annals of oncology, 2007-03, Vol.18 (3), p.453-460

2007

Volltextzugriff (PDF)

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides

The New England journal of medicine, 1989-12, Vol.321 (26), p.1784-1790

1989

Volltextzugriff (PDF)

Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer : A Southwest Oncology Group Study

Cancer research (Chicago, Ill.), 1998-03, Vol.58 (6), p.1149-1158

1998

Volltextzugriff (PDF)

HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients

British journal of cancer, 2005-12, Vol.93 (12), p.1334-1340

2005

Volltextzugriff (PDF)

Chemoprevention of lung cancer—from biology to clinical reality

Annals of oncology, 2004-02, Vol.15 (2), p.185-196

2004

Volltextzugriff (PDF)

Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1632-1641

1995

Volltextzugriff (PDF)

EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines

Annals of oncology, 2008-06, Vol.19 (6), p.1053-1059

2008

Volltextzugriff (PDF)

Lung Cancer Research and Treatment: Global Perspectives and Strategic Calls to Action

Annals of oncology, 2024-10

2024

Volltextzugriff (PDF)

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

Journal of clinical oncology, 2001-07, Vol.19 (13), p.3210-3218

2001

Volltextzugriff (PDF)

Early Detection of Lung Cancer: Clinical Perspectives of Recent Advances in Biology and Radiology

Clinical cancer research, 2001-01, Vol.7 (1), p.5-22

2001

Volltextzugriff (PDF)

Neuropeptide Stimulation of Calcium Flux in Human Lung Cancer Cells: Delineation of Alternative Pathways

Proceedings of the National Academy of Sciences - PNAS, 1990-03, Vol.87 (6), p.2162-2166

1990

Volltextzugriff (PDF)

Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

Journal of immunological methods, 1984-08, Vol.72 (1), p.77-89

1984

Volltextzugriff (PDF)

Small Cell Lung Cancer, Endocrine Cells of the Fetal Bronchus, and Other Neuroendocrine Cells Express the Leu-7 Antigenic Determinant Present on Natural Killer Cells

Blood, 1985-03, Vol.65 (3), p.764-768

1985

Volltextzugriff (PDF)

Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study

Journal of clinical oncology, 1995-12, Vol.13 (12), p.2924-2930

1995

Volltextzugriff (PDF)

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas

British journal of cancer, 2002-05, Vol.86 (9), p.1449-1456

2002

Volltextzugriff (PDF)

The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC

Drug design, development and therapy, 2018-01, Vol.12, p.981-986

2018

Volltextzugriff (PDF)

Fluorescence Versus White-Light Bronchoscopy for Detection of Preneoplastic Lesions: a Randomized Study

JNCI : Journal of the National Cancer Institute, 2001-09, Vol.93 (18), p.1385-1391

2001

Volltextzugriff (PDF)

Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib

Annals of oncology, 2006-07, Vol.17 (7), p.1120-1127

2006

Volltextzugriff (PDF)

Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo

Clinical cancer research, 1998-11, Vol.4 (11), p.2849-2858

1998

Volltextzugriff (PDF)

ErbB-3 expression is associated with E-cadherin and their coexpression restores response to gefitinib in non-small-cell lung cancer (NSCLC)

Annals of oncology, 2009-04, Vol.20 (4), p.689-695

2009

Volltextzugriff (PDF)

T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas

The New England journal of medicine, 1985-08, Vol.313 (9), p.534-538

1985

Volltextzugriff (PDF)

1 – 25 von 295

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(264)
Mit Volltextzugriff
(197)

Publikationsform

Artikel
(293)
magazinearticle
(2)

Sprache

Englisch
(295)

Erscheinungsjahr

n.n

Thema

Humans
(258)
Science & Technology
(221)
Life Sciences & Biomedicine
(215)
Oncology
(143)
Female
(102)
Male
(102)
Biological And Medical Sciences
(101)
Lung Neoplasms - Drug Therapy
(100)
Medical Sciences
(98)
Middle Aged
(86)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(69)
Aged
(66)
Adult
(65)
Lung Neoplasms - Pathology
(57)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(50)
Pharmacology. Drug Treatments
(50)
Antineoplastic Agents
(46)
Carcinoma, Small Cell - Drug Therapy
(45)
Animals
(35)
Antineoplastic Agents - Therapeutic Use
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Seminars In Oncology
(43)
Journal Of Clinical Oncology
(18)
Cancer Treatment Reports
(16)
Clinical Cancer Research
(16)
Blood
(15)
Cancer Research
(14)
Jnci : Journal Of The National Cancer Institute
(13)
Annals Of Oncology
(10)
Cancer
(8)
Annals Of Internal Medicine
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib

Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer

New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions

The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides

Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer : A Southwest Oncology Group Study

HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients

Chemoprevention of lung cancer—from biology to clinical reality

Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group

EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines

Lung Cancer Research and Treatment: Global Perspectives and Strategic Calls to Action

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

Early Detection of Lung Cancer: Clinical Perspectives of Recent Advances in Biology and Radiology

Neuropeptide Stimulation of Calcium Flux in Human Lung Cancer Cells: Delineation of Alternative Pathways

Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

Small Cell Lung Cancer, Endocrine Cells of the Fetal Bronchus, and Other Neuroendocrine Cells Express the Leu-7 Antigenic Determinant Present on Natural Killer Cells

Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas

The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC

Fluorescence Versus White-Light Bronchoscopy for Detection of Preneoplastic Lesions: a Randomized Study

Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib

Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo

ErbB-3 expression is associated with E-cadherin and their coexpression restores response to gefitinib in non-small-cell lung cancer (NSCLC)

T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas

Suchergebnisse filtern